This week, CRISPR Therapeutics rang the Opening Bell at Nasdaq Exchange in Times Square to celebrate our milestones and growth! We’re proud to ring in our success as a company and the impact we can have on people living with serious diseases: bit.ly/4dL3BfE

📸: Nasdaq, Inc.

CRISPR Therapeutics recognizes #NationalCancerResearchMonth , an awareness campaign initiated and supported by the AACR. This initiative aims to acknowledge the importance of innovative research to aid those who are impacted by cancer. Learn more: bit.ly/4aqqyma #NCRM24

As #precisionhealth and individualized medicine play a greater role in health care, Duke Clinical Research Institute, CRISPR Therapeutics, @Beamtx, @Intelliatx, & @Vervetx are partnering on the new #PrecisionHealthAlliance , focused on innovation in gene editing. Learn more here: phgea.org

Welcoming CRISPR Therapeutics to the Nasdaq Exchange Opening Bell. x.com/i/broadcasts/1…

CRISPR Therapeutics will ring the Opening Bell at Nasdaq Exchange in Times Square this morning to commemorate the first-ever approval of a CRISPR therapy and to celebrate innovation as our full pipeline advances. Tune in for the livestream here at 9:15am ET: nasdaq.com/marketsite/bel…

This week, Samarth Kulkarni, CRISPR Therapeutics CEO & Chairman, spoke at the Milken Institute Global Conference about biomedical breakthroughs, how to accelerate innovation and scalability, and the future for in vivo gene editing. Watch the replay here: bit.ly/3UDr0Xm #MIGlobal

Today, we announced our first quarter earnings results. Read more about our recent highlights and outlook: bit.ly/4dtPpYb  #CRSP #CRISPRTX

Today, we announced new preclinical data presented at the Annual Meeting of the American Society of Gene & Cell Therapy highlighting our approach to developing lipid nanoparticle (LNP) based delivery for in vivo ocular gene editing: bit.ly/3yejV8o ASGCT #ASGCT2024

In collaboration with Vertex Pharmaceuticals, we're pleased to share that we’ve published three new publications in The New England Journal of Medicine (NEJM) containing clinical data on the treatment for sickle cell disease and beta thalassemia.

We’re looking forward to presenting an oral presentation at the upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting on May 8, 2024. Learn more here: bit.ly/49NOBKv #ASGCT2024

The CRISPR era is here and we’re proud to be at the forefront. Thank you AtlanticLIVE for inviting our CEO Samarth Kulkarni to the #AtlanticHealth Summit to discuss how CRISPR is pioneering a new era of medicine with potential applications for a range of serious diseases. #CRISPRTX

We had the honor of attending the Life Science Cares Boston Impact Breakfast earlier this week. We’re proud to support their efforts in making a positive impact on our local community by volunteering and raising awareness about poverty and inequality. #CRISPRTX

On April 4th at 10am ET, our CEO Dr. Samarth Kulkarni Samarth Kulkarni will join The Atlantic's Health Summit to discuss the future of gene-editing technology. Learn more and register here: theatlantic.com/live/health-su… #AtlanticHealth

We’re pleased to announce the acceptance of an oral presentation at the upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting. Learn more here: bit.ly/4ahQVui #ASGCT2024

March 24th is Lipoprotein(a) Awareness Day. Did you know that Lp(a) is a genetic factor that increases the risk for both heart disease and stroke? Learn more at: bit.ly/48PrpLi #KnowLpa

We're pleased to invite Christian Rommel, Ph.D., to join our Board of Directors. His extensive experience accelerating innovation and advancing drug candidates across modalities will be invaluable as we continue to advance our platform and pipeline: bit.ly/3wQlSXH

On #RareDiseaseDay , our CEO Dr. Samarth Kulkarni Samarth Kulkarni joined CNBC’s Power Lunch discussing the science of gene editing and opportunities to efficiently scale the use of #CRISPR technology for a range of serious diseases. Watch here: bit.ly/48KgJhg

During International Women’s Day, CRISPR Therapeutics celebrates the achievements of women globally. Thank you to the women at the forefront of gene editing who are leading the charge to revolutionize the way we treat diseases. #IWD2024 #InspireInclusion

#RareDiseaseDay brings a global focus on efforts to raise awareness and support for individuals living with rare conditions. Learn more about this initiative and how you can get involved here: bit.ly/3GtUpe1

Today, we announced our fourth quarter and full year earnings results. Read more about our recent highlights and outlook: bit.ly/3UNvRqz #CRISPR #CRISPR TX